Parion Sciences Overview

  • Founded
  • 2000
Founded
  • Status
  • Private
  • Employees
  • 18
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $3M
Latest Deal Amount
  • Investors
  • 2

Parion Sciences General Information

Description

Operator of a development stage company dedicated to research, development, and commercialization of treatments for diseases with unmet medical needs. The company's technologies target respiratory, ocular, and other epithelial diseases resulting from the patient's ability to protect their mucosal surfaces is compromised, thereby enabling healthcare professionals to restore a patient's innate mucosal defense system.

Contact Information

Website
Formerly Known As
CyFi Inc.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Suite 195
  • 2800 Meridian Parkway
  • Durham, NC 27713
  • United States
+1 (919) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Parion Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Grant 16-Sep-2014 $3M 000.00 Completed Generating Revenue
9. Grant 01-Jan-2013 00.000 000.00 Completed Startup
8. Grant 01-Jan-2011 00.00 000.00 Completed Startup
7. Grant 01-Jan-2010 00000 000.00 Completed Startup
6. Grant 01-Jan-2009 00000 000.00 Completed Startup
5. Grant 01-Jan-2006 00000 000.00 Completed Startup
4. Later Stage VC (Series C) 10-Jan-2005 000.00 000.00 Completed Startup
3. Grant 01-Jan-2005 00000 000.00 Completed Startup
2. Angel (individual) 07-Jul-2003 $3.57M $10.1M Completed Startup
1. Angel (individual) 26-Nov-2002 $6.5M $6.5M Completed Startup
To view Parion Sciences’s complete valuation and funding history, request access »

Parion Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a development stage company dedicated to research, development, and commercialization of treatments for dise
Drug Discovery
Durham, NC
18 As of 2020
000.00
0000000000 000.00

00 00000

m, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irur
0000000000000
Durham, NC
000 As of 0000
00000
000000 - 000 00000

00000000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000 000000000
Exton, PA
000 As of 0000
0000
0000 0000-00-00
000000&0 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Parion Sciences Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
G1 Therapeutics Formerly VC-backed Durham, NC 000 00000 000000 - 000 00000
000000000 Formerly VC-backed Exton, PA 000 0000 000000&0 0000
0000 000 Venture Capital-Backed Durham, NC 00 000.00 00000000000 000.00
000000 00000 Private Equity-Backed Durham, NC 00 00000 000000000000 00000
00000 000000000 Formerly VC-backed Boulder, CO 000 00000 000000&0 00000
You’re viewing 5 of 11 competitors. Get the full list »

Parion Sciences Executive Team (5)

Name Title Board Seat Contact Info
Paul Boucher President, Chief Executive Officer & Board Member
Richard Boucher MD Co-Founder & Co-Chairman
Ross Johnson Ph.D Co-Founder & Co-Chairman
Alison Church MD Chief Medical Officer
To view Parion Sciences’s complete executive team members history, request access »

Parion Sciences Board Members (4)

Name Representing Role Since
Paul Boucher Parion Sciences President, Chief Executive Officer & Board Member 000 0000
Richard Boucher MD Parion Sciences Co-Founder & Co-Chairman 000 0000
Robert Wills Ph.D Self Board Member 000 0000
Ross Johnson Ph.D Parion Sciences Co-Founder & Co-Chairman 000 0000
To view Parion Sciences’s complete board members history, request access »

Parion Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Parion Sciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cystic Fibrosis Foundation Corporation 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Parion Sciences’s complete investors history, request access »